Bnp Paribas Asset Management Holding S.A. Regeneron Pharmaceuticals, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

  • $40.4 Billion
  • Q3 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 485,847 shares of REGN stock, worth $341 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
485,847
Previous 500,274 2.88%
Holding current value
$341 Million
Previous $526 Million 2.86%
% of portfolio
1.27%
Previous 1.36%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$1024.09 - $1201.76 $14.8 Million - $17.3 Million
-14,427 Reduced 2.88%
485,847 $511 Million
Q2 2024

Jul 29, 2024
BUY
$883.2 - $1071.19 $85 Million - $103 Million
96,266 Added 23.83%
500,274 $526 Million
Q1 2024

May 08, 2024
BUY
$902.69 - $993.35 $17 Million - $18.7 Million
18,788 Added 4.88%
404,008 $389 Million
Q4 2023

Feb 09, 2024
BUY
$775.18 - $881.7 $157 Million - $179 Million
202,735 Added 111.1%
385,220 $338 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $46.2 Million - $56.3 Million
66,664 Added 57.56%
182,485 $150 Million
Q2 2023

Aug 08, 2023
BUY
$700.03 - $830.35 $30.3 Million - $35.9 Million
43,259 Added 59.62%
115,821 $83.2 Million
Q1 2023

May 08, 2023
BUY
$680.49 - $826.97 $2.19 Million - $2.66 Million
3,218 Added 4.64%
72,562 $59.6 Million
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $487,064 - $528,809
-690 Reduced 0.99%
69,344 $50 Million
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $25.2 Million - $31.8 Million
43,926 Added 168.25%
70,034 $48.2 Million
Q2 2022

Aug 04, 2022
BUY
$548.35 - $738.84 $1.18 Million - $1.59 Million
2,156 Added 9.0%
26,108 $15.4 Million
Q1 2022

May 12, 2022
BUY
$595.12 - $698.43 $4.28 Million - $5.03 Million
7,200 Added 42.98%
23,952 $16.7 Million
Q4 2021

Feb 09, 2022
BUY
$543.48 - $670.97 $5.04 Million - $6.23 Million
9,281 Added 124.23%
16,752 $10.6 Million
Q3 2021

Nov 08, 2021
BUY
$574.03 - $680.96 $229,612 - $272,384
400 Added 5.66%
7,471 $4.52 Million
Q2 2021

Aug 05, 2021
SELL
$472.8 - $558.54 $686,978 - $811,558
-1,453 Reduced 17.05%
7,071 $3.95 Million
Q1 2021

May 05, 2021
SELL
$446.73 - $548.2 $184,946 - $226,954
-414 Reduced 4.63%
8,524 $4.03 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $23,915 - $30,399
50 Added 0.56%
8,938 $4.32 Million
Q3 2020

Nov 09, 2020
BUY
$544.75 - $658.21 $2.47 Million - $2.98 Million
4,528 Added 103.85%
8,888 $4.98 Million
Q2 2020

Aug 04, 2020
SELL
$493.32 - $643.92 $590,010 - $770,128
-1,196 Reduced 21.53%
4,360 $2.72 Million
Q1 2020

May 12, 2020
BUY
$336.18 - $494.43 $792,376 - $1.17 Million
2,357 Added 73.68%
5,556 $2.71 Million
Q4 2019

Feb 11, 2020
SELL
$274.13 - $376.51 $379,944 - $521,842
-1,386 Reduced 30.23%
3,199 $1.2 Million
Q3 2019

Nov 12, 2019
SELL
$273.46 - $318.39 $355,224 - $413,588
-1,299 Reduced 22.08%
4,585 $1.27 Million
Q2 2019

Aug 02, 2019
BUY
$299.6 - $414.82 $1.17 Million - $1.62 Million
3,895 Added 195.83%
5,884 $1.84 Million
Q1 2019

Apr 26, 2019
SELL
$372.08 - $439.57 $57,300 - $67,693
-154 Reduced 7.19%
1,989 $817,000
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $66,156 - $79,398
197 Added 10.12%
2,143 $777,000
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $42,839 - $49,838
122 Added 6.69%
1,946 $786,000
Q1 2018

May 07, 2018
BUY
$315.82 - $393.78 $82,113 - $102,382
260 Added 16.62%
1,824 $628,000
Q4 2017

Feb 01, 2018
SELL
$358.63 - $469.95 $49,132 - $64,383
-137 Reduced 8.05%
1,564 $588,000
Q3 2017

Nov 02, 2017
BUY
$431.38 - $504.0 $733,777 - $857,304
1,701
1,701 $761,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email